The pharmaceutical manufacturing industry is undergoing a phase of profound transformation. Increasingly complex processes, advanced automation, technological integration, and stringent regulatory requirements are redefining the standards of the entire sector.
In this context, the interview published in MakingLife with Cristiano Restelli, Sales Director of Tecninox, explores the company’s approach to designing customized systems for the biotech sector and for controlled contamination environments.
From Computational Fluid Dynamics (CFD) for airflow analysis, to LAF systems, VHP pass boxes, and containment solutions for cytotoxic applications, up to fully customized plants: each project originates from ongoing dialogue with the client and is developed through advanced integration between mechanical design and automation.
The goal is to ensure:
-
Technological integration
-
Safety and full regulatory compliance (GMP, FDA, EMA)
-
Operational efficiency
-
Long-term scalability
-
Truly tailor-made solutions
In a scenario where the demand for customization is constantly growing, Tecninox views complexity as an opportunity to innovate, investing in know-how, technologies, and continuous collaboration with its partners.
Here you can read the full interview published in MakingLife: Tecninox-interview-MakingLife-2025-10